JAMA Network
About The Study: This national analysis of Medicare beneficiaries undergoing cholecystectomy between 2020 and 2023 had 2 principal findings. First, the use of robotic-assisted cholecystectomy continued to increase substantially. Second, despite its growth, robotic-assisted cholecystectomy remained associated with higher risk-adjusted rates of bile duct injury compared with laparoscopic cholecystectomy, while differences in overall complication rates between approaches were small.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
